<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" >

   <HEAD>

	<TITLE>Human Active Adenosine Kinase Enzyme</TITLE>

	<!--[if IE 6]><meta http-equiv="Refresh" content="0; url=http://www.novocib.com/IE7/index.html"><![endif]-->

    <!--[if IE 7]><meta http-equiv="Refresh" content="0; url=http://www.novocib.com/IE7/index.html"><![endif]-->

    <META http-equiv=Content-Type content="text/html; charset=iso-8859-1">

	<META name=Title content="Active adenosine kinase enzyme -  purified human adenosine kinase">

	<META name=Author content="NovoCIB (lbalakireva@novocib.com)">

	<META name=Subject content=">

	<META name=Description content="NovoCIB's cloned human adenosine kinase - short form - is active enzyme characterised for its capacity to phosphorylate natural nucleosides adenosine and inosine and nucleoside antiviral analog ribavirine">

	<META name=Keywords content="buy adenosine kinase, human adenosine kinase, recombinant adenosine kinase, ADK, AK, Adenosine, Adenosine transport, in vitro phosphorylation ADK assay, adenosine kinase assay, drug discovery, nucleoside analogue phosphorylation, ribavirin phosphorylation, mizoribine phosphorylation, tiazofurin phosphorylation"> 

	<META content=en name=Language>

	<META content=" name=Expires>

	<META content="NOVOCIB � 2006" name=Distribution>

	<META content=All name=Robots>

	   <!-- css -->

	   <LINK href="css/Stylesmaller.css" type=text/css rel=stylesheet>

	   <!-- favico -->

	   <LINK href="http://www.novocib.com/favicon.ico" rel="shortcut icon">

	   <link rel="stylesheet" media="screen" type="text/css" title="Style" href="css/Stylesmaller.css">

<!-- end favico -->



<!-- script du menu -->

<script type="text/javascript" src="JavMenu.js"></script>

 <!-- d�t�ction du navigateur -->

<script type="text/javascript" src="navdetecteur.js"></script>



<!-- important pour que les vieux navigateurs ne comprennent pas le CSS -->

<style type="text/css">

    @import "Stylesmaller.css";

.style2 {

	font-size: 11px;

	font-weight: bold;

}

</style>



</head>

<body>

<div id="page">



<!--[if lt IE 8]><div align=left class="smallRed">This site is designed for IE 8 or IE 9. We are working for compatibility with lower versions. For better convenience, please visit us with IE 8, IE 9, Google Chrome or Firefox, or any other compatible navigator</div><![endif]-->



<!-- HEADER -->

<div id="header">

  <div id="headerLogo"><a href="http://www.novocib.com" title="NovoCIB Home Page"><img src="images/logo NovoCIB1.png" width="247" height="122"/></a></div>

    <p>&nbsp;

     </script>

<script src="//platform.linkedin.com/in.js" type="text/javascript">

 lang: en_US

</script>

<script type="IN/FollowCompany" data-id="5048147" data-counter="none"></script>

    <div id="headerSlogan"><SPAN class=ChapterThirdTitle><em>Reliable solutions for nucleotide assessment</em></SPAN><img src="images/HorizBarMenu.gif" width=380 /></div>

<div><a href="mailto:contact@novocib.com?subject=Contact" class="MenuContact" title="Contact">Contact</a>&nbsp;&nbsp;</div> <br /><br />

</div>

<!-- End HEADER -->



<!-- SQUARE RIGHT -->

<div id="SquareRight" class="small">

  

  <div align="center" class=ChapterThirdTitle style4>Award</div>

  <div align=center>Dr Larissa Balakireva, CEO &amp; Founder of NovoCIB, was awarded with the Trophy of

      <br /><a href="http://www.aufeminin.com/evenement/femmes-en-or/" Title="Femmes en Or 2011" class="boldRedAct" target=_blank>"Femmes en Or 2011, Femme de l'Innovation"</a>

      <br />in September 2011

  </div>.

  <div align=center><a href="http://www.aufeminin.com/evenement/femmes-en-or/" Title="Femmes en Or 2011" class="boldRedAct" target=_blank><img src="images/trophees femmes en or.jpg"/ width=100 ></a>

  </div>

  

    

</div>

<!-- End SQUARE RIGHT -->





<!-- MENU PRINCIPAL, HORIZONTAL -->

<div id="menu">

  <ul id="MenuDeroul">

    <li><a href="Purified_Active_Enzymes.html"><strong>PURIFIED<br />

    ENZYMES</strong></a>

        <ul>

            <li><a href="Recombinant_Purine_Metabolism_Enzymes.html">Purine Metabolism Enzymes</a>

                <ul>

                    <li><a href="IMPDH_Recombinant_Enzyme.html">IMPDH Enzymes<br /><span class="ItemNameHoriz">Inosine Monophosphate Dehydrogenase</span></a>

                        <ul>

                            <li><a href="Human_Recombinant_IMPDH.html">Human IMPDH</a></li>

                            <li><a href="Bacterial_Recombinant_IMPDH.html">Bacterial IMPDH</a></li>

                        </ul>

                    </li>

                    <li><a href="Human_Recombinant_PNP.html">PNP Enzyme<br /><span class=ItemNameHoriz>Purine Nucleoside Phosphorylase</span></a></li>

                     <li><a href="Xanthine_Dehydrogenase_XDH.html">XDH Enzyme<br /><span class=ItemNameHoriz>Xanthine dehydrogenase</span></a></li>

                    <li><a href="Human_Recombinant_HGPRT.html">HGPRT Enzyme<br /><span class=ItemNameHoriz>Hypoxanthine-guanine phosphoribosyltransferase</span></a></li>

                </ul>

            </li>

            <li><a href="Recombinant_Nucleoside_Kinases.html">Nucleoside Kinase  Nucleotidase</a>

                <ul>

                    <li><a href="Recombinant_Adenosine_Kinase.html">ADK Enzyme<br /><span class=ItemNameHoriz>Adenosine Kinase</span></a></li>

                    <li><a href="Recombinant_Deoxycytidine_Kinase.html">dCK Enzyme<br /><span class=ItemNameHoriz>Deoxycytidine Kinase</span></a></li>

                    <li><a href="Recombinant_UMP-CMP_Kinase.html">CMK Enzyme<br /><span class=ItemNameHoriz>UMP-CMP Kinase</span></a></li>

                    <li><a href="Recombinant_5'-nucleotidase.html">cN-II Enzyme<br /><span class=ItemNameHoriz>cytosolic 5'-nucleotidase II</span></a>            </li>

                </ul>

            </li>

            <li><a href="Bacterial_Bioluminescence_Enzymes.html">Bacterial Bioluminescence Enzymes</a>

                <ul>

                    <li><a href="Bacterial_Luciferase.html">Bacterial Luciferase, Highly Pure<br /><span class="ItemNameHoriz">from <em>Photobacterium phosphoreum</em></span></a></li>

                    <li><a href="Bacterial_FMN_Reductase.html">FMN Reductase<br /><span class="ItemNameHoriz">for Bacterial Bioluminescence</span></a>            </li>

                </ul>

            </li>

      </ul>

    </li>

    <li><a href="Nucleotides_Life_Science.html"><strong>NUCLEOTIDES<br /> 

      LIFE SCIENCE<br />

    </strong></a>	

        <ul>

          <li><a href="Convenient_Assay_Kits.html">Assay Kits</a>

          <li><a href="Cellular_Nucleotides_Analysis.html">HPLC Analysis</a>

  </ul>

   <li><a href="Freshness_Assay_Kits.html"><strong>NUCLEOTIDES<br />

      FRESHNESS</strong></a>

       <ul>

              <li><a href="Freshness_Principle.html">Kit Principle</a>

             <li><a href="Freshness_Protocol.html">How It Works</a>

             <li><a href="Case_Studies.html">Case Studies</a>

            <ul><li><a href="Fish_Freshness.html">Fish</a>

             <li><a href="Meat_Freshness.html">Meat</a>    

              </ul></li></ul>

    </li>

    <li><a href="Nucleotide_Analysis_Services.html"><strong>DIETARY<br />

      NUCLEOTIDES</strong></a>

      <ul> 

           

             <li><a href="Yeast_Extract_Nucleotide_Analysis.html">Yeast Extract</a></li>

            <li><a href="Infant_Formula_Nucleotide_Analysis.html">Infant Formula</a></li>

            <li><a href="Aquaculture_Nucleotide_Analysis.html">Aquaculture Feed</a></li>

            <li><a href="Feed_Nucleotide_Analysis.html">Feed &amp; Pet Food</a></li>

            <li><a href="By-Products_Nucleotides.html">By-Products Valorisation</a></li> 

            </ul>

      </li>

    <li><a href="ATP_Breakdown_Assay_Kit.html"><strong>SLAUGHTER<br />

      NUCLEOTIDES<br />

    </strong></a>	

        <ul>

        <li><a href="ATP_breakdown_salmon.html">Fish </a></li>

        <li><a href="ATP_breakdown_meat.html">Meat</a></li>

        </ul>

    </li>

  </ul>



</div>



<!-- End MENU PRINCIPAL, HORIZONTAL -->





<!-- Sub Menu, Vertical -->

<!-- End Sub Menu, Vertical -->

<br />

<!-- Tax Credit announcement -->

<!-- End Tax Credit announcement -->





<!-- page content -->

   

<div id="content" class="default">

  

  <div align="justify"> 

    <!-- Intro -->

    <table width=640>

    <tr><td><table width=640>

      <tr>

        <td><table width="250" id="ProductPicture">

           <tr>

            <td colspan=2 align=center class="zoomWidthW350-450"><p><img src="images/ADK Reaction.png" width="333" height="109" />

            <h2 class="ChapterThirdTitle">Adenosine Kinase</h2>

  <span class="big14bold">Ref. #E-Nov5</span>

                      </td>

          </tr>

          <tr>

            <td align=left><strong>Quantity</strong></td>

            <td align=right><strong>Price*</strong></td>

          </tr>

          <tr>

            <td align=left><strong>100 mUnits</strong></td>

            <td align=right><strong>&euro;355.00</strong></td>

          </tr>

          <tr>

            <td align=left><strong>200 mUnits</strong></td>

            <td align=right><strong>&euro; 565.00</strong></td>

          </tr>

          <tr>

            <td align=left><strong>500 mUnit</strong></td>

            <td align=right><strong>&euro; 1420.00</strong></td>

          </tr>

          <tr>

        <td colspan=2><p><span class="small">* Pricing updated December 8<sup>th</sup>, 2013</span>

        <br />

          <p>Provided in stable lyophilized form and <span class="defaultBlue"><strong>shipped without dry ice</strong></span><br />

          <strong>To order ADK <a href="mailto:contact@novocib.com?subject=ADK%20Enzyme%20Order" class="boldRedAct" title="ADK Enzyme Order">click here</a> or ask for</strong><strong></strong> <a href="mailto:contact@novocib.com?subject=ADK%20Enzyme%20Quotation%20Request" class="TabServRed" title="ADK enzyme quotation">Quotation</a>

          <br /> 

          <span class="style2">Bulk quantity available</span></td>

        </tr>

        </table>

          <h1 class="ChapterThirdTitle">Human  Adenosine Kinase (ADK, EC 2.7.1.20)</h1>

          

          <div class="small"><span class="smallbold">Synonyms:</span> ADK, Adenosine 5'-phosphotransferase

       </div>

       <br />

        <strong>NOVO</strong><span class="boldRed">CIB</span>'s human adenosine kinase is an active and purified, 345-aa short form<span class="medium"><sup>(14,2)</sup></span> ADK protein (<em></em>39kDa) cloned by RT-PCR amplification of mRNA extracted from human hepatoma cells and expressed in <em>E.coli</em>. The sequence of the cloned ADK (GenBank accession number U50196) was confirmed by DNA sequencing (100% identity).

             <p> Adenosine kinase is a key enzyme of <strong>nucleoside analogs activation</strong><br />

             For rapid evaluation of substrates properties of novel nucleoside analogs for human adenosine kinase see our <a href="http://www.novocib.com/ADK_Phosphorylation_Assay_Kit.html" class=TabServRed>PRECICE<sup>�</sup> ADK Phosphorylation Assay Kit</a>.

             <br  /><br />

             ADK is also a validated target for Drug Discovery: adenosine-regulating drugs have been extensively tested(1) as new analgesic and anti-inflammatory agents(4) to treat schizophrenia(7) or to limit brain injury after an ischemic stroke(8). 



             </p>

               </td>

      </tr>

    </table>

    

  

      

    </td>

    </tr>

    </table>

    <br />

    

    <!-- End Intro -->

  </div>

  

 

  

  <div id="PrincipalItem">

    <!-- Human Recombinant Adenosine kinase (AK) - Product description -->

  

    

       <br />

       Adenosine kinase is a ubiquitous enzyme that catalyzes the transfer of &gamma;-phosphate from ATP to 5&rsquo;-hydroxyl of adenosine (AR), an important modulator of central nervous system functions and a signal molecule involved in hypoxia, inflammation, and nociception. Together with adenosine deaminase, adenosine kinase regulates intra- and extracellular cellular adenosine concentration.

         Inhibition of adenosine kinase results in a selective increase of local adenosine concentrations and reduced seizure susceptibility and nociception <em>in vivo</em><span class="medium"><sup>(3)</sup></span>.  ADK dysfunction is  involved in several pathologies, including diabetes<sup>(13)</sup>, epilepsy<sup>(6)</sup>, and cancer. Consequently, ADK emerges as a rational therapeutic target for Drug Discovery, and adenosine-regulating drugs have been extensively <sup></sup>tested <sup>(1) </sup>as new analgesic and anti-inflammatory agents<span class="medium"><sup>(4) </sup></span>to treat  schizophrenia<span class="medium"><sup>(7)</sup></span> or to limit brain injury after an ischemic stroke<span class="medium"><sup>(8)</sup></span>. 

         <br />

         The X-ray crystallographic structure of human ADK has been described<span class=medium><sup>(9)</sup></span> and provides structural basis for rational design and optimisation of new ADK inhibitors.

        In addition, this enzyme is responsible for the phosphorylation and consequent clinical activity of several therapeutically useful nucleosides, including the antiviral drug ribavirin<span class=medium><sup>(10)</sup></span>, immunosuppressive drug mizoribine<span class=medium><sup>(11)</sup></span>, and anticancer C-nucleoside, tiazofurin<span class=medium><sup>(12)</sup></span>.           <br />

         </p>

         <table cellspacing=10 class=medium align=justify>

<tr valign=top>

                   <td width=300><div class="FloatLeft"><img src="images/AK Gel.png" height=200/></div>

                     <br /><br /><strong>Unit Definition:</strong> One unit of adenosine kinase converts 1.0 &micro;mole of inosine and ATP to IMP and ADP per minute at pH 8 at 37�C, as measured by a coupled IMPDH enzyme system.

                         <br />

(see <a href="http://www.novocib.com/ADK_Screening_Assay_Kit" title="ADK Assay Kit"><strong>ADK Assay Kit</strong></a>

              for further details)

               <br /><br />

                       <strong>Specific Activity:</strong> &ge; 0.200 unit/mg protein.

                       <br /><br />

                       <strong>Purity:</strong> controlled by 12% AA SDS-PAGE.

                   </td>

                   <td><strong>Assay condition:</strong> Enzymatic activity of adenosine kinase with particular nucleoside substrate is measured by spectrophotometric assays in a coupled lactate dehydrogenase / pyruvate kinase system. Assays were carried out at 37�C, at 50mM Tris-HCl pH7,6; 50mM KCl, 5mM MgCl<sub>2</sub>, 2.5mM ATP, 0.1mM NADH, 1mM phosphoenolpyruvate, 1mM DTT, PK 5U/ml, LDH 5U/ml. Reaction was followed in an iEMS Reader MF (Labsystems) microtiter plate reader at 340nm. Nucleosides, nucleotides, LDH and PK were purchased from Sigma-Aldrich.

                       <div align=center><img src="images/AK Kinetics.png" width=300/></div>

                   </td>

             </tr>

           </table>

          

           <!-- Bibliography -->

           <table class=small cellSpacing=0 cellPadding=5 align=center>

		       <tr><td valign=top><img src="images/iconsml.gif" width=100/>

                   </td>

			       <td><p><strong>References</strong><br />

                          1.  D. Boison (2013) Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev. 2013 Apr 16;65(3):906-43<br />

                          2. B. Sahin <em>et al.</em> (2004): Molecular characterization of recombinant mouse adenosine kinase and evaluation as a target for protein phosphorylation <em>Eur. J. Biochem.</em> 271(17), 3547-3555</a><br />

                          3. M. F. Jarvis <em>et al.</em> (2000): ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse <em>J. Pharmacol. Exp. Ther.</em> 295(3), 1156-1164</a><br />

                          4. S. McGaraughty <em>et al.</em> (2005): Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors <em>Curr. Top. Med. Chem.</em> 5(1):43-58</a><br />

                          5. D. E. Fedele <em>et al.</em> (2005): Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation <em>Brain</em> 128(Pt 10), 2383-2395</a><br />

                          6. D. Boison (2008): The adenosine kinase hypothesis of epileptogenesis <em>Prog. Neurobiol.</em> 84(3), 249-262</a><br />

                          7. D. Boison <em>et al.</em> (2011): Adenosine hypothesis of schizophrenia � Opportunities for pharmacotherapy <em>doi:10.1016/J.neuropharm.2011.01.048</em></a><br />

                          8. H. Y. Shen <em>et al.</em> (2011): Adenosine kinase determines the degree of brain injury after ischemic stroke in mice <em>J. Cereb. Blood Flow Metab. </em> 31(7): 1648-1659</a><br />

                          9. I. I. Mathews <em>et al.</em> (1998): Structure of human adenosine kinase at 1.5 A resolution <em>Biochemistry</em> 37(45): 15607-602</a><br />

                          10. R. C. Willis <em>et al.</em> (1978): Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell <em>Proc. Natl. Acad. Sci. USA</em> 75(7), 3042-3044</a><br />

                          11. R. L. Miller <em>et al.</em> (1979): Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity <em>J. Biol. Chem.</em>, 254(7), 2346�2352</a><br />                         

                           12. P. P. Saunders <em>et al.</em> (1990): Tiazofurin is phosphorylated by three enzymes from Chinese hamster ovary cells <em>Cancer Res.</em> 50(17), 5269-5274</a><br />                    

                          13. J.  Annes <em>et al.</em> (2012): Adenosine kinase inhibition selectively promotes rodent and porcine islet &beta;-cell replication</a> Proc. Natl. Acad. Sci. USA  Vol: 109:3915-3920<br />

                          14.

             J. Spychala <em>et al.</em> (1996): Cloning of human adenosine kinase cDNA: Sequence similarity to microbial ribokinases and fructokinases <em>Proc. Natl. Acad. Sci. USA</em> 93(3), 1232-1237</a>                   

	         </tr>

           </table>

           <!-- End Bibliography -->

           <div align=right class=medium>To know more about our <a href="http://www.novocib.com/Recombinant_Nucleoside_Kinases" class="mediumboldRedAct">Nucleoside kinases</a> catalogue.

           </div>

       </div>

    </p>

    <!-- End Human Recombinant Adenosine kinase (AK) - Product description -->

  </div>  

  

  <br />

  

  <div align="center">

    <table border=1 cellspacing=1 bordercolor=#cc0000>

        <tr align="center" bgcolor="#FFCC00" bordercolor=#ffffff>

            <td colspan="2"><span class="big16boldBlack">Related Links</span>

            </td>

        </tr>

        <tr align="left" valign=top bordercolor=#f5f5f5>

            <td class="RelatedLinksBullet">

            &bull; <a href="http://www.novocib.com/ADK_Assay_Kit.html" class="defaultAct">ADK Assay Kit</a><br />

            &bull; <a href="http://www.novocib.com/Recombinant_Nucleoside_Kinases.html" class="defaultAct">Nucleoside Kinases</a>

                <br />

                &bull; <a href="http://www.novocib.com/dCK_Assay_Kit.html" class="defaultAct">dCK Assay Kit</a>

                </td>

            <td class="RelatedLinksBullet">&bull; <a href="http://www.novocib.com/Recombinant_Deoxycytidine_Kinase.html" class="defaultAct">dCK enzyme</a>

              <br />&bull; <a href="http://www.novocib.com/Recombinant_UMP-CMP_Kinase.html" class="defaultAct">CMK enzyme</a>

                <br />&bull; <a href="http://www.novocib.com/Recombinant_5'-nucleotidase.html" class="defaultAct">cN-II enzyme</a>

            </td>

         

        </tr>

    </table>

  </div>



<!-- End page content -->



<!-- Go to Top of Page -->

<div id="GoToTopOfPage"><a href="#top">^Top of Page</a></div>

<!-- End Go to Top of Page -->



<!-- footer -->

<div id="footer"><br />

<SPAN class="Update">Last Update: 2022/02/18</SPAN><SPAN class="Copyright"> &copy; All Right Reserved | Copyright &reg; NovoCIB | L.Balakireva 2022 | </SPAN><a href="http://www.novocib.com/Legal_Notice" class="Legal" valign=top title="Legal Notice">Legal Notice</a>

</div>

<!-- End footer -->

</div>





<script type="text/javascript">

    initMenu();

</script>



<script>

  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){

  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),

  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)

  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');



  ga('create', 'UA-47165485-1', 'novocib.com');

  ga('send', 'pageview');



</script>

</body></html>